EP 3368526 B1 20191225 - CGRP RECEPTOR ANTAGONISTS
Title (en)
CGRP RECEPTOR ANTAGONISTS
Title (de)
CGRP-REZEPTOR-ANTAGONISTEN
Title (fr)
ANTAGONISTES DU RÉCEPTEUR CGRP
Publication
Application
Priority
- GB 201519194 A 20151030
- IB 2016056519 W 20161028
Abstract (en)
[origin: WO2017072723A1] The disclosures herein relate to heterocyclic calcitonin gene-related peptide (CGRP) antagonists of formula (I) useful in the treatment or prevention of cerebrovascular or vascular disorders such as migraine.
IPC 8 full level
C07D 401/14 (2006.01); A61K 31/4709 (2006.01); A61P 25/00 (2006.01); A61P 25/06 (2006.01); A61P 29/00 (2006.01)
CPC (source: EP US)
A61K 31/4709 (2013.01 - EP US); A61P 25/00 (2017.12 - EP US); A61P 25/06 (2017.12 - EP US); A61P 29/00 (2017.12 - EP US); C07D 401/14 (2013.01 - EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2017072723 A1 20170504; AR 106487 A1 20180117; AU 2016344689 A1 20180517; BR 112018008416 A2 20181023; CA 3002625 A1 20170504; CN 108430991 A 20180821; CN 108430991 B 20210105; EP 3368526 A1 20180905; EP 3368526 B1 20191225; GB 201519194 D0 20151216; IL 258894 A 20180628; JP 2018532790 A 20181108; JP 6874014 B2 20210519; SG 11201803382X A 20180530; TW 201722936 A 20170701; US 10166226 B2 20190101; US 2017121311 A1 20170504; US 2017239236 A1 20170824; US 2018153876 A1 20180607; US 9688660 B2 20170627; US 9925178 B2 20180327
DOCDB simple family (application)
IB 2016056519 W 20161028; AR P160103294 A 20161028; AU 2016344689 A 20161028; BR 112018008416 A 20161028; CA 3002625 A 20161028; CN 201680063940 A 20161028; EP 16808804 A 20161028; GB 201519194 A 20151030; IL 25889418 A 20180424; JP 2018541593 A 20161028; SG 11201803382X A 20161028; TW 105135025 A 20161028; US 201615336893 A 20161028; US 201715588051 A 20170505; US 201815882038 A 20180129